PF-06741086 — clinical trials using this drug

Public-registry trials using PF-06741086 that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.

Trial	Sponsor	Condition	Phase	Sites
Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B	Pfizer	Hemophilia A	PHASE3	62

Registry history

First registered study	August 2015 — NCT02531815 (Pfizer)
Registered studies matching this name	9 all-time · 3 currently recruiting

Source: ClinicalTrials.gov, the public trial registry.

Free site-risk snapshot for any of these trials

Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Related drugs & trials

Other Hemophilia A drugs

SerpinPC

← Eichor home · All tracked trials · Hemophilia A studies · Weekly briefs

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →